HTA25 Factors Including Real-World Evidence (RWE) That Play a Role in the HTA Recommendation of Oncology Drug Submissions Based on Phase II and/or Single Arm Trial Data
Abstract
Authors
Y. Patel S. Manjrekar K. Sripada I. Liu D. Shum